Pharmacokinetics of 10B-p-boronophenylalanine (BPA) in the blood and tumors in human patients: A critical review with special reference to tumor-to-blood (T/B) ratios using resected tumor samples

Appl Radiat Isot. 2020 Dec:166:109308. doi: 10.1016/j.apradiso.2020.109308. Epub 2020 Jul 26.

Abstract

We reviewed 10B concentration kinetics in the blood and tumors in human patients administered with BPA. The 10B concentration in the blood peaked at the end of intravenous infusion of BPA, followed by a biphasic-decreasing curve with half-lives for the first and second components of the curve being 0.7-3.7 and 7.2-12.0 h, respectively. The mean tumor-to-blood (T/B) ratio obtained from resected tumor samples was 3.40 ± 0.83 for melanoma and the ratio ranged from 1.4 to 4.7 for glioblastoma.

Keywords: (10)B-p-boronophenylalanine (BPA); BNCT; Blood; Pharmacokinetics; T/B ratio; Tumor.

Publication types

  • Review

MeSH terms

  • Boron / administration & dosage
  • Boron / blood
  • Boron / pharmacokinetics
  • Boron Compounds / administration & dosage
  • Boron Compounds / blood
  • Boron Compounds / pharmacokinetics*
  • Boron Neutron Capture Therapy / methods*
  • Brain Neoplasms / blood
  • Brain Neoplasms / metabolism
  • Brain Neoplasms / radiotherapy
  • Glioblastoma / blood
  • Glioblastoma / metabolism
  • Glioblastoma / radiotherapy
  • Humans
  • Isotopes / administration & dosage
  • Isotopes / blood
  • Isotopes / pharmacokinetics
  • Melanoma / blood
  • Melanoma / metabolism
  • Melanoma / radiotherapy
  • Neoplasms / blood
  • Neoplasms / metabolism
  • Neoplasms / radiotherapy*
  • Phenylalanine / administration & dosage
  • Phenylalanine / analogs & derivatives*
  • Phenylalanine / blood
  • Phenylalanine / pharmacokinetics
  • Positron-Emission Tomography

Substances

  • Boron Compounds
  • Boron-10
  • Isotopes
  • Phenylalanine
  • Boron
  • 4-boronophenylalanine